SCHEMBL23504528

SCHEMBL23504528

c1ccc(-c2c3ccccc3c(-c3ccc(-c4cccc5oc6ccccc6c45)c4c3oc3ccccc34)c3ccccc23)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC14B O60729 3/20 0.42
▸ CDC14A Q9UNH5 3/20 0.42
▸ ALOX5 P09917 2/20 0.39
▸ CA1 P00915 2/20 0.39
▸ CA2 P00918 2/20 0.39
▸ KDM4E B2RXH2 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ GLA P06280 2/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ MAPT P10636 3/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ CSF1R P07333 1/20 0.37
▸ PDGFRB P09619 1/20 0.37
▸ KIT P10721 1/20 0.37
▸ FLT3 P36888 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ HDAC6 Q9UBN7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23504602 0.98 ALOX5 (0.41) CDC14BCDC14AALOX5CA1CA2
SCHEMBL23504469 0.98 ALOX5 (0.41) CDC14BCDC14AALOX5CA1CA2
SCHEMBL23504477 0.95 ALOX5 (0.41) CDC14BCDC14AALOX5CA1CA2
SCHEMBL23504526 0.95 ALOX5 (0.41) CDC14BCDC14AALOX5CA1CA2
SCHEMBL23504690 0.94 CDC14B (0.43) CDC14BCDC14AALOX5CA1CA2
SCHEMBL23504511 0.94 ALOX5 (0.43) CDC14BCDC14AALOX5KDM4EALDH1A1
SCHEMBL23504704 0.93 ALOX5 (0.42) CDC14BCDC14AALOX5CA1CA2
SCHEMBL23504691 0.93 CDC14B (0.47) CDC14BCDC14AALOX5CA1CA2
SCHEMBL23504587 0.92 ALOX5 (0.42) CDC14BCDC14AALOX5KDM4EALDH1A1
SCHEMBL23427125 0.91 ALOX5 (0.41) CDC14BCDC14AALOX5CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11038123-B2 Compound and organic electronic device using the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2021-06-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11038123-B2 Compound and organic electronic device using the same CHRM1, CHRM2, C1S CDC14B 3827/4885CDC14A 3754/4885ALOX5 3207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback